Trelaget 100mg Tablet – Once-Daily Triple-Action Relief for Type-2 Diabetes
Trelaget 100mg Tablet – Once-Daily Triple-Action Relief for Type-2 Diabetes
Trelaget 100mg Tablet – Once-Daily Triple-Action Relief for Type-2 Diabetes
Description
Trelaget 100mg Tablet – Empagliflozin 10mg + Linagliptin 5mg + Metformin XR 1000mg in One Powerful Pill
Trelaget 100mg is the world’s first triple-combination tablet delivering Empagliflozin 10mg (SGLT2 inhibitor), Linagliptin 5mg (DPP-4 inhibitor) and extended-release Metformin 1000mg. One morning tablet lowers HbA1c by an average 1.8–2.1%, promotes 3–5 kg weight loss, reduces blood pressure, and cuts cardiovascular & kidney events by up to 40% – all with just a single daily dose. Perfect for patients already on dual therapy who need stronger control or anyone wanting maximum protection with minimum pills.
